Study the Anticancer Potentiality of a Natural Bioactive Compound Resveratrol in Combination with PARP Inhibitor Olaparib through deregulation of Homologous Recombination Repair Pathway in Pre-Clinical Model Systems of Breast Cancer

By: Material type: TextTextDDC classification:
  • 660 SIN
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)

Powered by Koha